ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

DCBD To Increase Emphasis On Workshops, Cut Program Initiatives

November 8, 1985

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

Court Could Determine Future of Clinical Trials in Abigail Alliance Case.

February 9, 2007

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

Ethics Commission Backs Limited Pilot Program for Compensation Of Injured Research Subjects

January 16, 1981

Stop Cancer Promises $7 Mil. By End Of Year

October 12, 1990